These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 16315222)
21. Heterogeneity of recombinant antibodies: linking structure to function. Harris RJ Dev Biol (Basel); 2005; 122():117-27. PubMed ID: 16375256 [TBL] [Abstract][Full Text] [Related]
22. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties. Carnahan J; Wang P; Kendall R; Chen C; Hu S; Boone T; Juan T; Talvenheimo J; Montestruque S; Sun J; Elliott G; Thomas J; Ferbas J; Kern B; Briddell R; Leonard JP; Cesano A Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3982S-90S. PubMed ID: 14506197 [TBL] [Abstract][Full Text] [Related]
23. Accessing the global minimum conformation of stefin A dimer by annealing under partially denaturing conditions. Jerala R; Zerovnik E J Mol Biol; 1999 Sep; 291(5):1079-89. PubMed ID: 10518944 [TBL] [Abstract][Full Text] [Related]
24. Facile method of quantification for oxidized tryptophan degradants of monoclonal antibody by mixed mode ultra performance liquid chromatography. Wong C; Strachan-Mills C; Burman S J Chromatogr A; 2012 Dec; 1270():153-61. PubMed ID: 23182937 [TBL] [Abstract][Full Text] [Related]
25. Crystal structure of the TCR co-receptor CD8alphaalpha in complex with monoclonal antibody YTS 105.18 Fab fragment at 2.88 A resolution. Shore DA; Teyton L; Dwek RA; Rudd PM; Wilson IA J Mol Biol; 2006 Apr; 358(2):347-54. PubMed ID: 16530222 [TBL] [Abstract][Full Text] [Related]
26. Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain. Yan B; Steen S; Hambly D; Valliere-Douglass J; Vanden Bos T; Smallwood S; Yates Z; Arroll T; Han Y; Gadgil H; Latypov RF; Wallace A; Lim A; Kleemann GR; Wang W; Balland A J Pharm Sci; 2009 Oct; 98(10):3509-21. PubMed ID: 19475547 [TBL] [Abstract][Full Text] [Related]
27. Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody. Liu H; Bulseco GG; Sun J Immunol Lett; 2006 Aug; 106(2):144-53. PubMed ID: 16831470 [TBL] [Abstract][Full Text] [Related]
28. Comparative binding of disulfide-bridged PEG-Fabs. Khalili H; Godwin A; Choi JW; Lever R; Brocchini S Bioconjug Chem; 2012 Nov; 23(11):2262-77. PubMed ID: 22994419 [TBL] [Abstract][Full Text] [Related]
30. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products. Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388 [TBL] [Abstract][Full Text] [Related]
31. Structure of IL-17A in complex with a potent, fully human neutralizing antibody. Gerhardt S; Abbott WM; Hargreaves D; Pauptit RA; Davies RA; Needham MR; Langham C; Barker W; Aziz A; Snow MJ; Dawson S; Welsh F; Wilkinson T; Vaugan T; Beste G; Bishop S; Popovic B; Rees G; Sleeman M; Tuske SJ; Coales SJ; Hamuro Y; Russell C J Mol Biol; 2009 Dec; 394(5):905-21. PubMed ID: 19835883 [TBL] [Abstract][Full Text] [Related]
32. A thermal-cycling method for disaggregating monoclonal antibody oligomers. Sadavarte RH; Ghosh R J Pharm Sci; 2014 Mar; 103(3):870-8. PubMed ID: 24549731 [TBL] [Abstract][Full Text] [Related]
33. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q. Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914 [TBL] [Abstract][Full Text] [Related]
34. Application of zero-length cross-linking to form lysozyme, horseradish peroxidase and lysozyme-peroxidase dimers: Activity and stability. Yaghoubi H; Khajeh K; Hosseinkhani S; Ranjbar B; Naderi-Manesh H Int J Biol Macromol; 2007 Dec; 41(5):624-30. PubMed ID: 17915308 [TBL] [Abstract][Full Text] [Related]
35. Folding and self-assembly of herpes simplex virus type 1 thymidine kinase. Wurth C; Thomas RM; Folkers G; Scapozza L J Mol Biol; 2001 Oct; 313(3):657-70. PubMed ID: 11676546 [TBL] [Abstract][Full Text] [Related]
36. [Studies on the properties of the component of plasmin-treated IgG and the relation between IgG aggregates and complement-fixing ability (author's transl)]. Funakoshi S Hokkaido Igaku Zasshi; 1974 Nov; 49(6):522-35. PubMed ID: 4283370 [TBL] [Abstract][Full Text] [Related]
37. Calcium-binding calmyrin forms stable covalent dimers in vitro, but in vivo is found in monomeric form. Sobczak A; Blazejczyk M; Piszczek G; Zhao G; Kuznicki J; Wojda U Acta Biochim Pol; 2005; 52(2):469-76. PubMed ID: 15933764 [TBL] [Abstract][Full Text] [Related]
38. Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation. Debaene F; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S Anal Chem; 2013 Oct; 85(20):9785-92. PubMed ID: 24007193 [TBL] [Abstract][Full Text] [Related]
39. Refined structure of an intact IgG2a monoclonal antibody. Harris LJ; Larson SB; Hasel KW; McPherson A Biochemistry; 1997 Feb; 36(7):1581-97. PubMed ID: 9048542 [TBL] [Abstract][Full Text] [Related]
40. Hydrophobic dimerization and thermal dissociation of perylenediimide-linked DNA hairpins. Hariharan M; Zheng Y; Long H; Zeidan TA; Schatz GC; Vura-Weis J; Wasielewski MR; Zuo X; Tiede DM; Lewis FD J Am Chem Soc; 2009 Apr; 131(16):5920-9. PubMed ID: 19382814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]